Milenko Cicmil

Milenko Cicmil is a highly accomplished individual with a strong background in molecular pharmacology and cell biology.

He holds a Doctor of Philosophy (Ph.D.) in Molecular Pharmacology from the University of Reading and a Bachelor's Degree in Cell/Cellular and Molecular Biology from King's College London.

Milenko has held prominent roles in various organizations, showcasing his expertise and leadership skills.

Currently, he serves as a Board Observer at Xilio Therapeutics, Inc. and as the Chairman of the Board at AMP Discovery.

His previous roles include Vice President Global Head of external Innovation at Ipsen, Vice President - Translational Biology at FogPharma, and various directorial positions at Merck.

Milenko Cicmil also has a rich research background, having worked as a Senior Research Scientist at AstraZeneca and GE Healthcare, and as a Research Fellow at Cancer Research UK.

His experience extends to roles such as Group Leader Integrative Pharmacology Discovery Bioscience - Inflammation at AstraZeneca.

With his diverse experience and strong educational foundation, Milenko Cicmil brings a wealth of knowledge to the field of pharmacology and innovation.